The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study
Year: 2001
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: British Journal of Dermatology
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Novartis Pharma
OpenAlex ID: W1985660464
